Arich Enterprise Co., Ltd. (TPEX:4173)
Taiwan · Delayed Price · Currency is TWD 20.60
-0.05 (-0.24%)
Apr 2, 2026, 1:30 PM CST
Arich Enterprise Market Cap
Arich Enterprise has a market cap or net worth of 1.54 billion as of April 2, 2026. Its market cap has decreased by -5.51% in one year.
Market Cap
1.54B
Enterprise Value
1.45B
Revenue
1.55B
Ranking
n/a
PE Ratio
17.76
Stock Price
20.60
Market Cap Chart
Since July 10, 2012, Arich Enterprise's market cap has increased from 863.24M to 1.54B, an increase of 77.96%. That is a compound annual growth rate of 4.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.54B | -2.37% |
| Dec 31, 2025 | 1.57B | -4.09% |
| Dec 31, 2024 | 1.64B | 0.23% |
| Dec 29, 2023 | 1.64B | 13.44% |
| Dec 30, 2022 | 1.44B | 7.50% |
| Dec 30, 2021 | 1.34B | -28.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 234.57B |
| Caliway Biopharmaceuticals | 148.78B |
| Bora Pharmaceuticals | 57.02B |
| Lotus Pharmaceutical | 56.77B |
| Tien Liang BioTech | 1.61B |
| Advagene Biopharma | 1.60B |
| GenMont Biotech Incorporation | 1.58B |
| InnoPharmax | 1.54B |